Dr. Rong Hai, along with other researchers at UC Riverside have developed a vaccine that speeds up antibody production against SARS-CoV-2. This new approach uses a combination of flu and COVID-19 proteins to rapidly activate the immune system. 

These findings were recently published in the Journal of Virology with the title Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.

The full article about these findings and the publication of this research can be found on the UCR News site titled, New vaccine design uses immunity against influenza to offer faster protection against emerging pathogens.